Drug Trial Radar · NCT01472614
Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus
Last checked: Nov 19, 2026Latest source record: May 27, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
54
Actual
Start
Sep 2011
Primary completion
Jan 2013
Study completion Apr 2013
Sponsor
- Lead sponsor
- Dexa Medica GroupIndustry
- Sponsor type
- Industry
- First posted
- Nov 16, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open clinical study for 12 weeks of therapy to investigate clinical efficacy and safety of an add-on therapy with DLBS3233 in improving blood glucose control, lipid profile, and adiponectin in subjects with type-2 diabetes mellitus.
Conditions
- Type-2 Diabetes Mellitus
Interventions
DLBS3233Drug
Study treatment will be DLBS3233 at a dose of 100 mg once daily (for 12 weeks) in addition to current anti-diabetic treatment used by respective study subjects and treatment intensification (lifestyle modification)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduction of A1c levelTime frame: 12 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Private Clinic at Jl. Prof. Dr. Moestopo 164
Surabaya, East Java, Indonesia
Surabaya Diabetes and Nutrition Centre, Dr. Soetomo Hospital
Surabaya, East Java, Indonesia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.